Quantum computing offers new opportunities for addressing complex classification tasks in biomedical applications. This study investigates two quantum machine learning models-the Quantum Support Vector Machine (QSVM) and the Variational Quantum Classifier (VQC)-in the context of B-cell epitope prediction, a key step in modern vaccine design. QSVM builds upon the classical SVM framework by using quantum circuits to encode nonlinear kernel computations, while VQC replaces the entire classification pipeline with trainable quantum circuits optimized variationally. A benchmark dataset from the Immune Epitope Database (IEDB) is used for model evaluation. Each epitope is represented by 10 physicochemical features, and dimensionality reduction via Principal Component Analysis (PCA) is applied to assess model performance across different feature spaces. We also examine the effect of sample size on prediction outcomes. Experimental results show that QSVM performs well under limited data conditions, while VQC achieves higher accuracy in larger datasets. These findings highlight the potential of quantum-enhanced models for bioinformatics tasks, particularly in supporting efficient and scalable epitope-based vaccine development.
Quantum computing offers new opportunities for addressing complex classification tasks in biomedical applications. This study investigates two quantum machine learning models-the Quantum Support Vector Machine (QSVM) and the Variational Quantum Classifier (VQC)-in the context of B-cell epitope prediction, a key step in modern vaccine design. QSVM builds upon the classical SVM framework by using quantum circuits to encode nonlinear kernel computations, while VQC replaces the entire classification pipeline with trainable quantum circuits optimized variationally. A benchmark dataset from the Immune Epitope Database (IEDB) is used for model evaluation. Each epitope is represented by 10 physicochemical features, and dimensionality reduction via Principal Component Analysis (PCA) is applied to assess model performance across different feature spaces. We also examine the effect of sample size on prediction outcomes. Experimental results show that QSVM performs well under limited data conditions, while VQC achieves higher accuracy in larger datasets. These findings highlight the potential of quantum-enhanced models for bioinformatics tasks, particularly in supporting efficient and scalable epitope-based vaccine development.
This study investigates quantum computing's role in B-cell epitope prediction using Quantum Support Vector Machine (QSVM) and Variational Quantum Classifier (VQC). It highlights the potential of quantum machine learning in bioinformatics, addressing computational efficiency limitations of traditional methods as data complexity grows. QSVM uses quantum kernel functions for data mapping, while VQC employs parameterized quantum circuits for classification. Results show QSVM and VQC achieving 70% and 73% accuracy, respectively, with QSVM excelling in balancing classes. Despite challenges like computational demands and hardware limitations, quantum methods show promise, suggesting future improvements with ongoing advancements.
Quantum Machine Learning (QML) has emerged as a promising paradigm for addressing increasing computational and representational demands in materials informatics. While classical models such as Support Vector Machines (SVM) achieve strong predictive performance, they often struggle to capture complex, highly correlated interactions in high-dimensional materials data. QML addresses this challenge by leveraging quantum-mechanical principles to construct expressive feature embeddings, where prospective quantum advantage lies in generating feature spaces that are difficult to approximate classically. In this study, 1,000 crystalline compounds from the Open Quantum Materials Database (OQMD) are evaluated in a binary classification task based on formation-energy stability. The dataset is normalized, reduced to four dimensions via Principal Component Analysis (PCA), and encoded into quantum circuits. Three QML models—QSVM, VQC, and QNN—are benchmarked against a classical SVM using repeated stratified evaluation. Results show that the classical SVM achieves the highest accuracy (91.8% ± 0.012), followed by QSVM (60.8% ± 0.035), while VQC and QNN perform significantly worse. This gap is driven by limited qubit capacity, encoding inefficiencies, restricted circuit expressivity, and optimization challenges. Nevertheless, QSVM demonstrates stable performance, suggesting that potential quantum advantage may emerge from improved feature encoding and kernel design rather than deeper variational circuits.
Blood glucose is one of the key indicators influencing the body’s metabolic performance. Accurate prediction and proactive management of this parameter are of paramount clinical importance. In this context, the analysis and evaluation of quantum machine learning (QML) algorithms for processing medical data and enhancing the predictive accuracy of health-related models have emerged as cutting-edge research directions in recent studies. Leveraging the principles of quantum physics and computation, QML algorithms serve as a promising alternative to classical methods for predicting chronic diseases. By mapping classical data into a quantum feature space and exploiting intrinsic quantum properties such as superposition and entanglement, these algorithms significantly enhance the ability to detect complex and latent patterns within datasets. In this study, the dataset was first preprocessed using Principal Component Analysis (PCA) for dimensionality reduction and noise suppression. Subsequently, the predictive performance of two quantum machine learning models—the Quantum Support Vector Machine (QSVM) and the Variational Quantum Circuit (VQC)—was evaluated and compared with that of the classical Support Vector Machine (SVM) for blood glucose level prediction. The results indicate that the QSVM model achieves a prediction accuracy of 90%, outperforming the classical SVM, which attained an accuracy of 74.4%. Moreover, the hybrid classical–quantum VQC model demonstrated the highest predictive performance, achieving an accuracy of 94.2%, thereby establishing it as the most effective approach for blood glucose level forecasting in this experimental setting.
Early and accurate diagnosis of breast cancer plays a critical role in improving patient survival rates and reducing treatment costs. Classical machine learning algorithms such as Logistic Regression and Support Vector Machines (SVM) have demonstrated strong performance in medical diagnosis tasks; however, their scalability and representational limits motivate the exploration of emerging paradigms. Quantum Machine Learning (QML), particularly Variational Quantum Classifiers (VQC), has recently gained attention due to its potential to model complex decision boundaries using quantum circuits. This paper presents a comparative analysis between a Variational Quantum Classifier and classical machine learning models for binary breast cancer classification. The study employs dimensionality-reduced clinical data and evaluates model performance using accuracy, confusion matrices, decision boundary visualization, Principal Component Analysis (PCA), and Receiver Operating Characteristic (ROC) curves. Experimental results indicate that the VQC achieves competitive performance with classical approaches, demonstrating its feasibility for small-scale medical datasets and highlighting the promise of quantum-enhanced learning in healthcare applications.
This paper evaluates the performance of two quantum machine learning algorithms: Quantum Support Vector Machine (QSVM) and Quantum Principal Component Analysis (Q-PCA). The scalability of QSVM is analyzed across increasing dataset sizes and feature dimensions, revealing faster-than-linear growth in kernel evaluation and SVM training times. However, this computational overhead is accompanied by a notable decline in classification accuracy, highlighting challenges in applying QSVM to larger or more complex datasets. In contrast, Q-PCA demonstrates near-linear scalability with dataset size and qubit count, leveraging the independence of quantum circuit execution and structured operations to maintain efficiency. A QNN-based implementation of Q-PCA further validates its ability to align data with principal components, maximize variance, and enable effective dimensionality reduction. These findings emphasize the potential of Q-PCA for efficient quantum-enhanced data analysis while underscoring the need for optimization in QSVM and further exploration of Q-PCA’s capabilities for real-world quantum computing applications.
A potential path forward is Quantum Machine Learning (QML), which aims to leverage quantum computing in conjunction with classical machine learning to enhance computing efficiency and the expressiveness of models. In this paper, two different quantum classifiers - Variational Quantum Classifier (VQC) and Quantum Kernel Support Vector Machine (QSVM) - are compared with three classical classifiers as baseline classifiers - Logistic Regression, Support Vector Machine (SVM), and a Multi-Layer Perceptron (MLP) - on the Breast Cancer Wisconsin dataset. The quantum circuits were created in the PennyLane framework and simulated on a classical backend. However, in terms of accuracy, classical Logistic Regression performed better with an accuracy of 97.8%, classical SVM and QSVM with an accuracy of 95.6% each, although the Quantum VQC achieved a lower accuracy of 88.9% and had a recall of 100% for the benign class, though it correctly identified only 12 of the 17 malignant cases (a malignant-class recall of approximately 70.6%). The drawback of quantum models is the higher training time; however, since the quantum circuit needs to be classically simulated, the quantum SVM took 23.29 seconds compared to less than 0.01 seconds for the classical linear models. These results indicate that for small structured datasets, classifiers based on quantum computing have not yet surpassed well-tuned classical counterparts. In some respects (e.g., benign-class recall), they perform competitively, though not on malignant-class recall, where the VQC in particular performed worse than the classical baselines, which is worth further investigation on real quantum computers.